Michael Berndt

Michael Berndt serves as an Honorary Professor at the John Curtin School of Medical Research (JCSMR), part of the Australian National University. His collaborative work with The Gardiner Group centers on unraveling the complex mechanisms linking thrombosis and cancer.

Professor Berndt's primary research interests lie in the intersection of thrombosis and cancer. His work explores how blood clotting disorders influence cancer progression and metastasis, and vice versa. This research is critical for developing new therapeutic strategies for cancer patients who are at high risk of thrombotic events. His expertise spans hematology, oncology, and molecular mechanisms of disease.

He is actively involved as a collaborator in The Gardiner Group at JCSMR, a research team dedicated to understanding the molecular and cellular mechanisms underlying thrombosis and its relationship with cancer. This group is part of JCSMR's broader efforts in cancer and cardiovascular research.